PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-2.4%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.32B
AUM Growth
-$203M
(-3.7%)
Cap. Flow
-$59.9M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
23.94%
Holding
303
New
29
Increased
89
Reduced
98
Closed
32
Top Buys
| 1 |
Union Pacific
UNP
|
$48M |
| 2 |
Gilead Sciences
GILD
|
$37.7M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$33.4M |
| 4 |
CVS Health
CVS
|
$29.7M |
| 5 |
Danaher
DHR
|
$28.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$36.9M |
| 2 |
PNC Financial Services
PNC
|
$34M |
| 3 |
CELG
Celgene Corp
CELG
|
$31.5M |
| 4 |
Accenture
ACN
|
$29.9M |
| 5 |
Waste Connections
WCN
|
$29M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Healthcare | 23.21% |
| 3 | Financials | 21.91% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Willis Towers Watson
WTW
$32.1B
| $11.3M | 0.21% |
+95,000
| New | +$11.3M |
|
|
LOGM
127
DELISTED
LogMein, Inc.
LOGM
| $11.2M | 0.21% |
221,288
+42,092
| +23% | +$2.12M |
|
128
Applied Materials
AMAT
$130B
| $11M | 0.21% |
518,594
+114,616
| +28% | +$2.43M |
|
129
Synaptics
SYNA
$2.7B
| $11M | 0.21% |
137,627
-166,485
| -55% | -$13.3M |
|
130
NetEase
NTES
$85B
| $10.9M | 0.2% |
378,510
-96,445
| -20% | -$2.77M |
|
131
RLI Corp
RLI
$6.16B
| $10.9M | 0.2% |
325,000
-5,000
| -2% | -$167K |
|
132
SiriusPoint
SPNT
$2.19B
| $10.8M | 0.2% |
950,000
| – | – |
|
133
Heritage Insurance Holdings
HRTG
$747M
| $10.8M | 0.2% |
675,000
+75,000
| +13% | +$1.2M |
|
134
Aflac
AFL
$57.2B
| $10.7M | 0.2% |
340,000
-5,000
| -1% | -$158K |
|
135
UBS Group
UBS
$128B
| $10.7M | 0.2% |
657,754
+89,322
| +16% | +$1.45M |
|
136
Ralph Lauren
RL
$18.9B
| $10.2M | 0.19% |
105,445
-874
| -0.8% | -$84.1K |
|
137
Adobe
ADBE
$148B
| $9.38M | 0.18% |
99,977
+22,758
| +29% | +$2.13M |
|
138
OneSpan
OSPN
$583M
| $9.34M | 0.18% |
606,693
-116,435
| -16% | -$1.79M |
|
|
CELG
139
DELISTED
Celgene Corp
CELG
| $9.02M | 0.17% |
90,149
-314,702
| -78% | -$31.5M |
|
140
Wells Fargo
WFC
$253B
| $9M | 0.17% |
186,218
+12,420
| +7% | +$601K |
|
|
TSRO
141
DELISTED
TESARO, Inc.
TSRO
| $8.81M | 0.17% |
200,000
-245,853
| -55% | -$10.8M |
|
142
Progressive
PGR
$143B
| $8.79M | 0.17% |
250,000
-51,500
| -17% | -$1.81M |
|
143
Align Technology
ALGN
$10.1B
| $8.72M | 0.16% |
+120,000
| New | +$8.72M |
|
144
Inogen
INGN
$219M
| $8.71M | 0.16% |
193,524
-106,776
| -36% | -$4.8M |
|
145
Dynavax Technologies
DVAX
$1.18B
| $8.27M | 0.16% |
430,000
-650,944
| -60% | -$12.5M |
|
146
AbbVie
ABBV
$375B
| $8.05M | 0.15% |
141,027
-106,539
| -43% | -$6.08M |
|
|
ELGX
147
DELISTED
Endologix Inc
ELGX
| $7.96M | 0.15% |
95,271
-90,009
| -49% | -$7.52M |
|
|
ULTI
148
DELISTED
Ultimate Software Group Inc
ULTI
| $7.85M | 0.15% |
40,542
+21,239
| +110% | +$4.11M |
|
149
Ares Capital
ARCC
$15.8B
| $7.78M | 0.15% |
525,000
+60,000
| +13% | +$890K |
|
|
150
Bristol-Myers Squibb
BMY
$96B
| $7.66M | 0.14% |
120,000
-578,070
| -83% | -$36.9M |
|